drugset / Trial / NCT01384396
A Clinical Study of KW-3357 in Patients With DIC
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the efficacy and safety of KW-3357 with concomitant use of heparin using multi-center, non-comparative, open-label method in patients diagnosed as disseminated intravascular coagulation (DIC) by the diagnostic criteria for DIC established by the Japanese Ministry of Health and Welfare.
Timeline
- Start
- 2011-12
- Primary completion
- 2013-04
- Completion
- 2013-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KW-3357 | Protein / enzyme biologic | — | Intravenous |